I. Wiegand
Nature Protocols · 2008
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Whom I. Wiegand trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts I. Wiegand overall
Papers from I. Wiegand's perspective
Ordered by how strongly the researchers I. Wiegand trusts endorse each paper. Same corpus, a different order for every researcher.
- Determination of minimum inhibitory concentrations. (Journal of Antimicrobial Chemotherapy)
- Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies (Nature Biotechnology)
- Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. (Clinical Infectious Diseases)
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
- Peptide Antimicrobial Agents (Clinical Microbiology Reviews)
- Defensins: antimicrobial peptides of innate immunity (Nature reviews. Immunology)
- The co-evolution of host cationic antimicrobial peptides and microbial resistance (Nature Reviews Microbiology)
- Mammalian defensins in immunity: more than just microbicidal. (Trends in immunology)
- Mechanisms of Antimicrobial Peptide Action and Resistance (Pharmacological Reviews)
- How Toll-like receptors signal: what we know and what we don't know. (Current Opinion in Immunology)